HAIR STYLING PATENTS FOR 2006 - Patent and Intellectual ...

www.FormulaScan.com - Patents listed by Formula Scan were retrieved by parsing the claims in the original documents.
Our lists have greater than 95% relevance to the subject
US Patent No: 6703536
Disposable absorbent article having a skin care composition containing an enzyme inhibitor
An absorbent article, at least a portion of which comprises a skin care composition that comprises
an enzyme inhibitor and is at least partially transferred from the article to the skin of a wearer of the
article as a result of normal contact, wearer motion and/or body heat. The enzyme inhibitor is
transferred to the skin with the skin care composition and is available at the skin/urine and
skin/feces interfaces to inhibit enzymatic activity on the skin and to reduce or prevent the
occurrence of inflammation. Repeated application of similar treated articles to the wearer's skin
provides an available source with which the enzyme inhibitor transfers onto the skin continuously
over time and accumulates to provide a proactive defense against harmful enzymes for the
treatment and/or prevention of diaper dermatitis.
US Patent No: 6710066
Photochemotherapeutic method using 5-aminolevulinic acid and other precursors of endogenous
porphyrins
Methods of detecting and treating rapidly growing exogenous cells, such as Protista, or parasites,
that preferentially accumulate a photoactivatable porphyrin in which 5-aminolevulinic acid or
precursor thereof is administered to the patient, or contacted to the exogenous cells, in an amount
sufficient to induce synthesis fluorescence and/or photosensitizing concentrations of a
protoporphyrin IX in the exogenous cells, followed by exposure of the exogenous cells to light of
photoactivating wavelengths.
US Patent No: 6719986
Hyaluronate lyase used for promoting penetration in topical agents
The invention relates to an agent for treating skin diseases and/or functional disorders of the skin on
the basis of different medicaments and/or auxiliary substances through promotion of penetration
from topical formulations into the skin. According to the invention, the agent is composed of a
hyaluronate lyase produced by microbial means and a medicament, preferably a hydrophilic
medicament and/or auxiliary substances in different galenic formulations including colloidal carrier
systems. The areas of application for the invention in human and veterinary medicament relate to
the treatment, prophylaxis and/or metaphylaxis of skin diseases, functional disorders of the skin,
the processes of skin ageing and dry skin conditions.
This document was prepared by www.FormulaScan.com. Its reproduction in any type of form or format is strictly prohibited without
the written consent of Formula Scan